IL6 and COVID-19: Similarly, a study of 137 hospitalized patients with COVID-19 (of whom 56 were critically ill) found that the AAT:IL-6 ratio (reverse ratio from aforementioned study) was lower in non-survivors and those with thrombosis [64].